Abandon the Amyloid Hypothesis? New Research Says Not So Fast Nov 26, 2012 After the recent failures of two Alzheimer’s drugs that target amyloid beta plaques, many have questioned the approach. But new data released in October shows promise. Skin Cancer Drug Effective in Mice with Alzheimer’s, Should We Prescribe Off-Label? Nov 12, 2012 Should a drug that’s effective in animals against the underlying pathology of Alzheimer’s, but proven safe in humans for leukemia be prescribed off-label? AstraZeneca, Unraveling the Neuroscience of Alzheimer’s Nov 05, 2012 For November’s focus on Alzheimer’s, we’re featuring an article written by an AstraZeneca scientist, published on their new company blog, Lab Talk.
Abandon the Amyloid Hypothesis? New Research Says Not So Fast Nov 26, 2012 After the recent failures of two Alzheimer’s drugs that target amyloid beta plaques, many have questioned the approach. But new data released in October shows promise.
Skin Cancer Drug Effective in Mice with Alzheimer’s, Should We Prescribe Off-Label? Nov 12, 2012 Should a drug that’s effective in animals against the underlying pathology of Alzheimer’s, but proven safe in humans for leukemia be prescribed off-label?
AstraZeneca, Unraveling the Neuroscience of Alzheimer’s Nov 05, 2012 For November’s focus on Alzheimer’s, we’re featuring an article written by an AstraZeneca scientist, published on their new company blog, Lab Talk.
